As of mid-June 2026, the CDC has confirmed 2,073 measles cases nationwide, already approaching the full-year 2025 total of 2,288 and reflecting sustained community transmission primarily among unvaccinated or unknown-status individuals (93% of cases). Major ongoing outbreaks, including those originating in 2025 in South Carolina and Utah, account for most infections, with 30 new outbreaks reported this year and the majority locally acquired rather than imported. Lower MMR vaccination coverage in specific communities, combined with high measles transmissibility (R0 of 12–18), drives the elevated case counts relative to pre-2025 baselines. Weekly CDC surveillance updates on confirmed cases and outbreaks represent key upcoming data releases that could shift totals before year-end resolution.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
ผู้ป่วยโรคหัดในสหรัฐอเมริกาในปี 2026?
$7,732,579 ปริมาณ
$7,732,579 ปริมาณ
Dec 31, 2026
↑3k
75%
↑4k
31%
↑5k
18%
↑7.5k
12%
↑10k
7%
↑12.5k
5%
$7,732,579 ปริมาณ
$7,732,579 ปริมาณ
Dec 31, 2026
↑3k
$68,344 ปริมาณ
75%
↑4k
$181,302 ปริมาณ
31%
↑5k
$223,418 ปริมาณ
18%
↑7.5k
$178,434 ปริมาณ
12%
↑10k
$6,507,723 ปริมาณ
7%
↑12.5k
$347,594 ปริมาณ
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-June 2026, the CDC has confirmed 2,073 measles cases nationwide, already approaching the full-year 2025 total of 2,288 and reflecting sustained community transmission primarily among unvaccinated or unknown-status individuals (93% of cases). Major ongoing outbreaks, including those originating in 2025 in South Carolina and Utah, account for most infections, with 30 new outbreaks reported this year and the majority locally acquired rather than imported. Lower MMR vaccination coverage in specific communities, combined with high measles transmissibility (R0 of 12–18), drives the elevated case counts relative to pre-2025 baselines. Weekly CDC surveillance updates on confirmed cases and outbreaks represent key upcoming data releases that could shift totals before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ตลาดเปิดเมื่อ: Feb 16, 2026, 11:51 AM ET
ปริมาณการซื้อขาย
$7,732,579วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-June 2026, the CDC has confirmed 2,073 measles cases nationwide, already approaching the full-year 2025 total of 2,288 and reflecting sustained community transmission primarily among unvaccinated or unknown-status individuals (93% of cases). Major ongoing outbreaks, including those originating in 2025 in South Carolina and Utah, account for most infections, with 30 new outbreaks reported this year and the majority locally acquired rather than imported. Lower MMR vaccination coverage in specific communities, combined with high measles transmissibility (R0 of 12–18), drives the elevated case counts relative to pre-2025 baselines. Weekly CDC surveillance updates on confirmed cases and outbreaks represent key upcoming data releases that could shift totals before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
ปริมาณการซื้อขาย
$7,732,579วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-June 2026, the CDC has confirmed 2,073 measles cases nationwide, already approaching the full-year 2025 total of 2,288 and reflecting sustained community transmission primarily among unvaccinated or unknown-status individuals (93% of cases). Major ongoing outbreaks, including those originating in 2025 in South Carolina and Utah, account for most infections, with 30 new outbreaks reported this year and the majority locally acquired rather than imported. Lower MMR vaccination coverage in specific communities, combined with high measles transmissibility (R0 of 12–18), drives the elevated case counts relative to pre-2025 baselines. Weekly CDC surveillance updates on confirmed cases and outbreaks represent key upcoming data releases that could shift totals before year-end resolution.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย